Morgane Cellier

Morgane Cellier

Auto-generated profile, based on publicly available information

Morgane Cellier

Centre Antipoison d'Angers, CHU d’Angers

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in European Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
FJFabrice Jollant
Fabrice Jollant
IBIngrid Blanc-Brisset
Ingrid Blanc-Brisset
MCMorgane Cellier
Morgane Cellier
MAMarine AMBAR AKKAOUI
Marine AMBAR AKKAOUI
VTViet Chi Tran
Viet Chi Tran
DVDominique Vodovar
Dominique Vodovar
Concerns have been raised about early vs. later impacts of the COVID-19 pandemic on suicidal behavior. However, data remain sparse to date. We investigated all calls for intentional drug or other toxic ingestions to the eight Poison Control Centers in France between 1st January 2018 and 31st May 2022. Data were extracted from the French National Database of Poisonings. Calls during the study period were analyzed using time trends and time series analyses with SARIMA models (based on the first two years). Breakpoints were determined using Chow test. These analyses were performed together with examination of age groups (≤ 11, 12–24, 25–64, ≥ 65 years) and gender effects when possible. Over the studied period, 66,589 calls for suicide attempts were received. Overall, there was a downward trend from 2018, which slowed down in October 2019 and was followed by an increase from November 2020. Number of calls observed during the COVID period were above what was expected. However, important differences were found according to age and gender. The increase in calls from mid-2020 was particularly observed in young females, while middle-aged adults showed a persisting decrease. An increase in older-aged people was observed from mid-2019 and persisted during the pandemic. The pandemic may therefore have exacerbated a pre-existing fragile situation in adolescents and old-aged people. This study emphasizes the rapidly evolving situation regarding suicidal behaviour during the pandemic, the possibility of age and gender differences in impact, and the value of having access to real-time information to monitor suicidal acts.

24 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ACAlexandre Crosnier
Alexandre Crosnier
CAChadi ABBARA
Chadi ABBARA
MCMorgane Cellier
Morgane Cellier
LLLaurence Lagarce
Laurence Lagarce
MBMarina Babin
Marina Babin
MBMarie Briet
Marie Briet
Kidney EGFR expression together with reported cases of glomerular diseases in the context of anti-EGFR drug administration raise concerns about the renal safety profile of these drugs. This issue is addressed in a case/non-case study carried out on VigiBase®, the WHO global database of individual case safety reports (ICRS). Disproportionality analysis of renal adverse effects related to the selected anti-EGFR drugs, erlotinib, gefitinib, afatinib, osimertinib, cetuximab and panitumumab, was assessed using the reporting odds ratio (ROR). Nine hundred and eighty-nine ICRSs were included. A signal of disproportionate reporting (SDR) was found for afatinib (ROR = 2.70; 95% CI [2.22–3.29]) and erlotinib (ROR = 1.73; 95% CI [1.46–2.04]) with acute kidney injury, and for afatinib (ROR = 2.41; 95% CI [1.78–3.27]), cetuximab (ROR = 1.42; 95% CI [1.14–1.78]) and erlotinib (ROR = 2.23; 95% CI [1.80–2.77]) with renal failure. The preferred term “diarrhoea” was frequently reported in the included cases. An SDR was found for erlotinib with haemolytic and uremic syndrome (ROR = 4.01; 95% CI [1.80–8.94]) and thrombotic microangiopathy (ROR = 4.94; 95% CI [2.80–8.72]). No SDR was seen for glomerular or tubule-interstitial diseases. This study showed that the anti-EGFR drug renal toxicity is mainly related to renal failure in the context of digestive toxicity.

29 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MCMorgane Cellier
Morgane Cellier
DBDelphine Bourneau-Martin
Delphine Bourneau-Martin
CAChadi ABBARA
Chadi ABBARA
ACAlexandre Crosnier
Alexandre Crosnier
LLLaurence Lagarce
Laurence Lagarce
MBMarie Briet
Marie Briet
Background: Alongside their BCR-ABL specificity, TKIs used in chronic myeloid leukemia also target other tyrosine kinases expressed in the kidney such as PDGFR, c-KIT, SRC, and VEGFR, which may result in specific renal adverse drug reaction (ADR). To evaluate the renal safety profile in real-life conditions, a case/non-case study was performed on VigiBase®, the WHO global safety database. Methods: From 7 November 2001 to 2 June 2021, all cases in which the involvement of imatinib, dasatinib, nilotinib, bosutinib, and ponatinib was suspected in the occurrence of renal ADR were extracted from VigiBase®. Disproportionality analyses were assessed using the reporting odds ratio. Results: A total of 1409 cases were included. Imatinib accounts for half of the reported cases. A signal of disproportionate reporting (SDR) of renal failure and fluid retention was found for the five TKIs. Only dasatinib and nilotinib were related to an SDR for nephrotic syndrome. Nilotinib and ponatinib were related to an SDR for renal artery stenosis, while dasatinib was related to an SDR for thrombotic microangiopathy. No SDR for tubulointerstitial nephritis was observed. Conclusion: This study identified a new safety signal, nephrotic syndrome, for nilotinib and highlights the importance of post-marketing safety surveillance.

12 February 2022 in Laboratory Medicine
Verified
Journal Article
Closed access
MCM Cellier
M Cellier
NAN Anthony
N Anthony
CBC Bruneau
C Bruneau
ADA Descatha
A Descatha
Objective: To evaluate a potential association between blood and urine concentration of glyphosate and its metabolite, aminomethylphosphonic acid (AMPA), with severity of acute glyphosate (herbicide) poisoning. Methods: In our retrospective study of acute glyphosate poisoning, we examined records from the French National Database of Poisonings, dated between January 1, 2004, and December 31, 2016. We compared the severity of poisoning among case individuals using the Fisher exact test and Wilcoxon test. Also, we calculated ROC curves to determine the cutoff for blood and urine concentration. Results: A total of 17 plasma glyphosate, 11 urine glyphosate, 13 plasma AMPA, and 10 urine AMPA specimens were included in our study, with collection dates ranging from January 1, 2004, through December 31, 2016. Conclusion: The optimal cutoff we discovered for blood concentration of AMPA was 0.88 mg/L; for glyphosate, it was 600 mg/L. The cutoff plasma concentration of AMPA has never been described in the literature, to our knowledge.

1 July 2021 in Animal
Verified
Journal Article
Open access
BNB.L. Nielsen
B.L. Nielsen
MCM. Cellier
M. Cellier
CDC. Duvaux-Ponter
C. Duvaux-Ponter
Sylvie Giger-ReverdinSylvie Giger-Reverdin
Sylvie Giger-Reverdin
Few studies have investigated how meal patterns of ruminants are affected by diet fibre content. Dairy goats (N = 32) in late lactation and early gestation were housed in eight groups of four goats, with all combinations of breed (Alpine and Saanen) and lactation number (1 and 2) represented in each group. Each goat had access to its own individual feed trough placed on a weigh scale with data logged automatically. All goats were fed the same total mixed ration (TMR; 30% concentrate and 44.6% NDF in DM) ad libitum for a control period of 22 days. Using the same feed ingredients, half of the groups were then offered a High fibre diet (20% concentrate; 47.3% NDF), and the other half a Low fibre diet (40% concentrate; 41.5% NDF) for a treatment period of 16 days. Daily meal patterns (meal frequency, duration and size, feeding rate, daily feed intake and daily feeding time) were computed for each animal using a meal criterion of 8 min. The last 10 days for each period (control and treatment) were used to calculate individual period means and individual differences between the two periods. During the control period, the goats ate on average 12.1 ± 0.49 meals/day, consuming 4.2 ± 0.10 kg fresh TMR daily. When the ration changed, all measures of feeding behaviour except meal size changed asymmetrically for the goats on the two diets. Goats fed the High fibre diet reduced their meal frequency by 10%, and the first meal after feed distribution lasted 11% longer, leading to a 9% reduction in feeding rate and no significant changes in daily feed intake and daily feeding time. Goats on the Low fibre diet did not significantly change their meal frequency or meal size, but the combined changes nevertheless led to a 9% increase in daily feed intake. On the Low fibre diet, goats were able to increase their feeding rate by a third, leading to a reduction in meal durations, thus reducing daily feeding time by 13%. Goats adapt their feeding behaviour to the fibre proportion of the offered diet, with more changes when fibre content is lowered, which needs to be taken into account when comparing phenotypes and adaptability of small ruminants to different diets.

1 February 2023 in Clinical Toxicology
Verified
Journal Article
Closed access
MCMorgane Cellier
Morgane Cellier
JLJérémy Lecot
Jérémy Lecot
CBChloe Bruneau
Chloe Bruneau
MDMarie Deguigne
Marie Deguigne
MFMarc Fadel
Marc Fadel
ADAlexis Descatha
Alexis Descatha
Dear Editor,We have read with interest the paper “Amanitin intoxication: effects of therapies on clinical outcomes – a review of 40 years of reported cases” [1].There are no worldwide accepted guid...